Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Domchek

Showing results (1-10 of 361) with videos related to

Pageof 37
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 14, 2019
Germline genetic testing for breast cancer: which patients? What genes?Susan M Domchek
JAMA|December 7, 2018
Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex DiscussionSusan M Domchek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Therapeutic Considerations in Early-Stage, Estrogen Receptor-Positive, <i>BRCA</i>-Associated Breast CancerSusan M Domchek
Cancer Discovery|September 3, 2017
Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many VersionsSusan M Domchek
Breast Cancer Research : BCR|March 7, 2002
The utility of ductal lavage in breast cancer detection and risk assessmentSusan M Domchek
Clinical Advances in Hematology & Oncology : H&O|June 1, 2018
The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancerSusan M Domchek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Evolution of genetic testing for inherited susceptibility to breast cancerSusan M Domchek
Journal of the National Cancer Institute|August 29, 2015
BRIP1 as an ovarian cancer susceptibility gene: ready for the clinic?Judith Balmaña, Susan M Domchek
Annual Review of Medicine|December 4, 2024
New Therapeutic Options for BRCA Mutant PatientsAnthony Ghanem, Susan M Domchek
Seminars in Oncology|October 9, 2007
The prevention of hereditary breast cancerEstelamari Rodriquez, Susan M Domchek
Pageof 37

Showing results (1-10 of 361) with videos related to

Sort By:
Pageof 37
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 14, 2019
Germline genetic testing for breast cancer: which patients? What genes?Susan M Domchek
JAMA|December 7, 2018
Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex DiscussionSusan M Domchek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2026
Therapeutic Considerations in Early-Stage, Estrogen Receptor-Positive, <i>BRCA</i>-Associated Breast CancerSusan M Domchek
Cancer Discovery|September 3, 2017
Reversion Mutations with Clinical Use of PARP Inhibitors: Many Genes, Many VersionsSusan M Domchek
Breast Cancer Research : BCR|March 7, 2002
The utility of ductal lavage in breast cancer detection and risk assessmentSusan M Domchek
Clinical Advances in Hematology & Oncology : H&O|June 1, 2018
The evolution of poly(ADP-ribose) polymerase inhibitors in the treatment of breast cancerSusan M Domchek
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2014
Evolution of genetic testing for inherited susceptibility to breast cancerSusan M Domchek
Journal of the National Cancer Institute|August 29, 2015
BRIP1 as an ovarian cancer susceptibility gene: ready for the clinic?Judith Balmaña, Susan M Domchek
Annual Review of Medicine|December 4, 2024
New Therapeutic Options for BRCA Mutant PatientsAnthony Ghanem, Susan M Domchek
Seminars in Oncology|October 9, 2007
The prevention of hereditary breast cancerEstelamari Rodriquez, Susan M Domchek
Pageof 37